Regeneron's lead counsel was Jonathan D. Polkes of White & Case LLP.

While many pharma and biotech companies developing drugs to treat Alzheimer's disease are targeting amyloid beta plaque, Eli ...

BioNTech's BNT324 aims to outpace rivals in cancer treatment with its unique bispecific antibody design. Read more here.

Around 2,000 direct and over 1,500 indirect employment opportunities are expected to be generated by Sapigen Biologix.

Sheila Mikhail sold her biotech company in a $4 billion deal a few years ago. Now, after battling cancer, she's on a mission ...

For patients, CytomX's drug represents a new hope, particularly for the sickest of the sick with late-stage metastatic ...

In a world where western firms increasingly seek to ingratiate themselves with Middle Eastern leaders and investors, a Saudi ...

GT Biopharma, Inc. (the "Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative ...

We believe that Merck KGaA enjoys a narrow moat, driven by intangible assets and switching costs which are prevalent in its Life Science and Electronics businesses. A few acquisitions to fill gaps in ...

PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the ...

Israeli artificial intelligence biotech startup SpotitEarly Ltd. today officially launched in the U.S. and announced that it ...

The Garden State is looking to grow into the next big biotech hub. | The Garden State is looking to grow into the next big ...